Literature DB >> 27797318

Graves' Disease.

Terry J Smith1, Laszlo Hegedüs1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27797318     DOI： 10.1056/NEJMra1510030

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  258 in total

Review 1.  Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment.

Authors:  Faraat Ali; Anushma Chorsiya; Varisha Anjum; Asad Ali
Journal:  Int Ophthalmol       Date:  2021-01-22       Impact factor: 2.031

Review 2.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

3.  Severe cholestatic hyperbilirubinaemia secondary to thyrotoxicosis complicated with bile cast nephropathy treated with plasma exchange and haemodialysis.

Authors:  Anthony J Ocon; Matthew Rosenblum; James Desemone; Richard Blinkhorn
Journal:  BMJ Case Rep       Date:  2019-06-05

4.  The longer the antithyroid drug is used, the lower the relapse rate in Graves' disease: a retrospective multicenter cohort study in Korea.

Authors:  So Young Park; Bo Hyun Kim; Mijin Kim; A Ram Hong; Jun Park; Hyunju Park; Min Sun Choi; Tae Hyuk Kim; Sun Wook Kim; Ho-Cheol Kang; Jae Hoon Chung
Journal:  Endocrine       Date:  2021-04-15       Impact factor: 3.633

5.  Teprotumumab: a new avenue for the management of moderate-to-severe and active Graves' orbitopathy?

Authors:  E Piantanida; L Bartalena
Journal:  J Endocrinol Invest       Date:  2017-06-20       Impact factor: 4.256

6.  Therapeutic challenge of a paediatric case of Graves' disease with severe ophthalmopathy.

Authors:  Carla Ferreira; Carla Meireles; Olinda Marques; Ana Antunes
Journal:  BMJ Case Rep       Date:  2017-03-16

7.  Calculating the incalculable. Optimal radioiodine dose in Graves' hyperthyroidism.

Authors:  Laszlo Hegedüs; Steen J Bonnema
Journal:  Endocrine       Date:  2017-02-10       Impact factor: 3.633

8.  Hyperthyroidism After Radiation Therapy for Childhood Cancer: A Report from the Childhood Cancer Survivor Study.

Authors:  Peter D Inskip; Lene H S Veiga; Alina V Brenner; Alice J Sigurdson; Evgenia Ostroumova; Eric J Chow; Marilyn Stovall; Susan A Smith; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Charles A Sklar; Jay H Lubin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-02-12       Impact factor: 7.038

9.  Clinical association between thyroid disease and immune thrombocytopenia.

Authors:  Shoko Ito; Shin-Ichiro Fujiwara; Rui Murahashi; Hirotomo Nakashima; Sae Matsuoka; Takashi Ikeda; Shin-Ichiro Kawaguchi; Yumiko Toda; Tetsuaki Ban; Takashi Nagayama; Kento Umino; Daisuke Minakata; Kaoru Morita; Hirofumi Nakano; Ryoko Yamasaki; Masahiro Ashizawa; Chihiro Yamamoto; Kaoru Hatano; Kazuya Sato; Iekuni Oh; Ken Ohmine; Yoshinobu Kanda
Journal:  Ann Hematol       Date:  2020-11-09       Impact factor: 3.673

10.  Slit2 Modulates the Inflammatory Phenotype of Orbit-Infiltrating Fibrocytes in Graves' Disease.

Authors:  Roshini Fernando; Ana Beatriz Diniz Grisolia; Yan Lu; Stephen Atkins; Terry J Smith
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.